According to FutureWise analysis, the Metabolomics market in 2026 is US$3.29 billion, and is expected to reach US$8.87 billion by 2036 at a CAGR of 10.43%. 

The metabolomics market is experiencing rapid growth, propelled by advancements in technologies such as mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, and bioinformatics, which enable comprehensive metabolite profiling. The increasing applications of metabolomics in drug discovery, biomarker identification, and precision medicine are expanding its influence in the pharmaceutical, biotechnology, and clinical research sectors. Furthermore, the integration of metabolomics with genomics and proteomics in multi-omics approaches is providing deeper insights into disease mechanisms and therapeutic responses. The growing use of metabolomics in areas such as cancer research, cardiovascular studies, and microbiome analysis is driving demand for metabolomics services and platforms. Academic and research institutions are significant end-users of these technologies, while pharmaceutical companies are increasingly using metabolomics for patient stratification and optimizing clinical trials. Technological innovations in high-throughput screening and data analysis software are reducing costs and improving accessibility, thereby democratizing metabolomics research across various application areas through 2036.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Metabolomics Market trends that shall affect the overall market growth.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=10409&type=requestsample

By Product & Service

• Metabolomics Instruments
• Separartion Tools
• Gas Chromatography
• High-performance Liquid Chromatography
• Ultra-performance Liquid Chromatography
• Capillary Electrophoresis
• Detection Tools
• Nuclear Magnetic Resonance (NMR) Spectroscopy
• Mass Spectrometry (MS)
• Surface-Based Mass Analysis
• Metabolomics Bioinformatics Tools and Services
• Bioinformatics Services
• Bioinformatics Tools and Databases

By Application

• Biomarker discovery
• Drug discovery
• Toxicology testing
• Nutrigenomics
• Functional Genomics
• Personalized medicine
• Other Applications

By Indication

• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Metabolic Disorders
• Inborn Errors of Metabolism
• Other Indications

By End User

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Other End Users

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Metabolomics Market:

• Waters Corporation (US)
• Agilent Technologies (US)
• Shimadzu Corporation (Japan)
• Thermo Fisher Scientific (US)
• Danaher Corporation (US)
• Bruker Corporation (US)
• PerkinElmer (US)
• Merck KGaA (Germany)
• GE Healthcare (US)
• Hitachi High-Technologies Corporation (Japan)
• Human Metabolome Technologies, Inc. (Japan)
• LECO Corporation (US)
• Metabolon, Inc. (US)
• Bio-Rad Laboratories (US)
• Scion Instruments (US)
• DANI Instruments S.p.A. (Italy)
• GL Sciences (Japan)
• SRI Instruments (US)
• Kore Technology Ltd. (UK)
• JASCO, Inc. (US)

Buy now the latest version of this report:

https://www.futurewiseresearch.com/checkout.aspx?ReportId=10409&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Metabolomics Market By Product & Service, By Application, By Indication, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com